https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33308090/apelliss-stock-under-pressure-on-syfovre-safety-concerns-analyst-slashes-price-targ
Apellis's Stock Under Pressure On Syfovre Safety Concerns: Analyst Slashes Price Target - Apellis...
Jul 20, 2023 - Since Friday, Apellis Pharmaceuticals Inc (NASDAQ: APLS) shares have plummeted around 50% after the stock came under pressure following the disclosure of
https://www.healthdirect.gov.au/medicines/brand/amt,717198481000036109/syfovre
Syfovre | healthdirect
On this page about Syfovre you will find information relating to side effects, age restrictions, food interactions, whether the medicine is available at a...
healthdirect